ArticleFrontiers in bioengineering and biotechnology2025
An injectable curcumin-loaded hydrogel for neuroprotective treatment promote nerve tissue repair in rat severe spinal cord injury.
Article in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Reprogramming the oxidative microenvironment: Antioxidant nanoplatforms for central nervous system repair.Materials today. Bio · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Spinal Cord Injury (SCI) leads to severe motor and sensory impairments and underscores the urgent need for the development of effective treatment approaches. The injury microenvironment with oxidation, inflammation and extracellular matrix disruption represents a major barrier to nerve tissue repair as well as the functioning of therapeutic factors. Methods: This study proposes a curcumin-loaded boronate-crosslinked tannic acid injectable hydrogel (CBT-gel) for effective antioxidants and neuroprotective spinal cord repair. Rat transection SCI models were established, and the CBT-gel was implanted in the injured spinal cord tissue. Behavioral and histological testing was performed to determine the spinal cord repair effects. Results: The injectable self-healing hydrogel induced sustainable release of the neuroprotective drug curcumin. The CBT-gel transplantation treatment enhanced axonal preservation and reduced glial scar formation. The results also revealed a reduction in neuroinflammation and cellular oxidative damage. Discussion: These findings support the potential of CBT-gel to improve the microenvironment for spinal cord repair by leveraging their antioxidant and neuroprotective properties. The results in this study aligns with the documented bioactivity of curcumin, though molecular targets in the CBT-gel treatment require further profiling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.